PRPop Rahela Roxana

Pop Rahela Roxana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pop Rahela Roxana has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Francisc Boda

    Department F1, General and Inorganic Chemistry, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania

    1 shared publication
  • Gâz Șerban Andrei

    Department of Organic Chemistry, Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology “George Emil Palade” of Targu Mures, Targu Mures, Romania

    1 shared publication

Latest Publications

  • Imidazole Derivatives and their Antibacterial Activity - A Mini-Review

    by Gâz Șerban Andrei, Boda Francisc Andrei, Pop Rahela Roxana

    Background: The development of drug resistance by bacterial strains is a public health issue, being the main cause for the decrease in effectiveness of numerous antibiotics. In this context, it is essential to find new drugs with better antibacterial activity. Objective: The authors proposed to cover relevant literature, published following the review article written by Rani et al., illustrating chemical structures and antibacterial activity of some imidazole derivatives. Method: Approximately 100 scientific articles, presenting more than 150 compounds have been reviewed. The most relevant data have been extracted and systematically arranged in figures and tables. Results: The reviewed studies used a broad number of bacterial strains, however Staphylococcus aureus as Gram-positive, and Escherichia coli as Gram-negative bacterial strains were most frequently used to assess the activity of these compounds. Conclusion: Some of the compounds showed promising results against both Gram-positive and Gram-negative bacterial strains, thus further analysis should be performed in terms of toxicity, pharmacokinetics and pharmacodynamics. Additional screening of these imidazole derivatives could lead to useful compounds with potential broad-spectrum antibacterial activity against resistant pathogens.